Literature DB >> 24736838

Ocular albinism type 1-induced melanoma cell migration is mediated through the RAS/RAF/MEK/ERK signaling pathway.

Jun Bai1, Xin Xie2, Yun Lei1, Gaili An1, Li He1, Xiaopeng Lv3.   

Abstract

Malignant melanoma has the highest risk of mortality among all types of skin cancer due to its highly metastatic potential. The ocular albinism type 1 (OA1) protein is a pigment cell‑specific glycoprotein, which shares significant structural and functional features with G protein‑coupled receptors. However, the role of OA1 in melanoma has yet to be elucidated. The present study aimed to investigate whether OA1 is involved in melanoma cell migration. OA1 was found to stimulate cell migration in a dose‑dependent manner in cultured human melanoma cells. Furthermore, knockdown of OA1 using small interfering RNA was observed to significantly inhibit melanoma cell migration. In addition, the mechanism underlying OA1‑induced melanoma cell migration was investigated. Stimulation of the RAS/RAF/mitogen activated protein kinase kinase (MEK)/extracellular signal‑regulated kinase (ERK) pathway using growth factors enhanced OA1 expression and melanoma cell migration, whereas inhibition of this pathway using U0126 was observed to markedly decrease OA1 expression and the number of migrated cells. These findings indicate that OA1 is involved in melanoma cell migration and that OA1‑induced melanoma cell migration is mediated through the RAS/RAF/MEK/ERK signaling pathway. Therefore, OA1 may serve as a novel therapeutic target for melanoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24736838     DOI: 10.3892/mmr.2014.2154

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Effects of nuclear factor-κB and ERK signaling transduction pathway inhibitors on human melanoma cell proliferation in vitro.

Authors:  Yi-Chuan Huang; Min Pan; Ning Liu; Jun-Gang Xiao; Hong-Quan Chen
Journal:  Oncol Lett       Date:  2015-09-03       Impact factor: 2.967

2.  MiR-192-5p regulates the proliferation and apoptosis of cholangiocarcinoma cells by activating MEK/ERK pathway.

Authors:  Chaofeng Tang; Peng Yuan; Jian Wang; Yubo Zhang; Xiaowei Chang; Dong Jin; Peng Lei; Zhenhui Lu; Bendong Chen
Journal:  3 Biotech       Date:  2021-01-28       Impact factor: 2.406

3.  A novel locus on chromosome 1 underlies the evolution of a melanic plumage polymorphism in a wild songbird.

Authors:  Yann X C Bourgeois; Boris Delahaie; Mathieu Gautier; Emeline Lhuillier; Pierre-Jean G Malé; Joris A M Bertrand; Josselin Cornuault; Kazumasa Wakamatsu; Olivier Bouchez; Claire Mould; Jade Bruxaux; Hélène Holota; Borja Milá; Christophe Thébaud
Journal:  R Soc Open Sci       Date:  2017-02-15       Impact factor: 2.963

4.  GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors.

Authors:  Krishna Sriram; Kevin Moyung; Ross Corriden; Hannah Carter; Paul A Insel
Journal:  PLoS Biol       Date:  2019-11-25       Impact factor: 8.029

Review 5.  The Many Faces of G Protein-Coupled Receptor 143, an Atypical Intracellular Receptor.

Authors:  Beatriz Bueschbell; Prashiela Manga; Anke C Schiedel
Journal:  Front Mol Biosci       Date:  2022-04-12

6.  Instillation of Sericin Enhances Corneal Wound Healing through the ERK Pathway in Rat Debrided Corneal Epithelium.

Authors:  Noriaki Nagai; Yuya Fukuoka; Miyu Ishii; Hiroko Otake; Tetsushi Yamamoto; Atsushi Taga; Norio Okamoto; Yoshikazu Shimomura
Journal:  Int J Mol Sci       Date:  2018-04-09       Impact factor: 5.923

7.  Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells.

Authors:  Shaojun Wang; Xiaofei Zhang; Guimei Wang; Bin Cao; Hong Yang; Lipeng Jin; Mingjuan Cui; Yongjun Mao
Journal:  BMC Cancer       Date:  2019-11-29       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.